At a glance
- Originator ARYx Therapeutics
- Class Antiarrhythmics; Benzofurans
- Mechanism of Action Beta-adrenergic receptor antagonists; Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Arrhythmias